Literature DB >> 17950077

Publication bias in surgery: implications for informed consent.

Dora Syin1, Tinsay Woreta, David C Chang, John L Cameron, Peter J Pronovost, Martin A Makary.   

Abstract

BACKGROUND: Patients consenting for pancreas surgery are often quoted an operative risk of 1% to 3% based on the literature. However, these results are often from centers of excellence, and as a result the literature mortality rates may not be representative or generalizable.
METHODS: A MEDLINE search was performed to identify the major studies of pancreaticoduodenectomy (PD) and total pancreatectomy (TP) over a 6-y period (January 1998-December 2003). To obtain a literature-based mortality rate, we performed a meta-analysis of these published series and compared them with actual in-hospital mortality rates based on a representative 20% sample of hospital data in 37 states (the Nationwide Inpatient Sample). The sample included approximately 8 million patient records per year. Literature versus actual mortality rates were compared for the same 6-y period and stratified by academic versus nonacademic medical centers.
RESULTS: We identified 16 major studies on PD and TP totaling 3641 patients with an overall mortality rate of 3.2% (range 0%-9.3%). The actual mortality rate based on the Nationwide Inpatient Sample (n = 7604) was 2.4-fold higher than the literature rate (adjusted rate of 7.6% versus 3.2%, P < 0.0001). All literature-based series were published from academic medical centers. By contrast, in the national database, 26.3% of PDs (2003/7604) were performed at nonacademic medical centers with a mortality rate of 11.4% (229/2003). The actual mortality rate at academic medical centers was lower than nonacademic medical centers (6.4% (360/5601), P < 0.0001), but still higher than the literature-based rate of 3.2% (P < 0.0001).
CONCLUSIONS: Mortality rates for pancreatic resections in actual practice are 2.4-fold higher than those reported in the literature. Proper informed consent for surgical procedures should include an accurate description of the risks, using actual local and national mortality rates.

Entities:  

Mesh:

Year:  2007        PMID: 17950077     DOI: 10.1016/j.jss.2007.03.035

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Outcomes Improvement Is Not Continuous Along the Learning Curve for Pancreaticoduodenectomy at the Hospital Level.

Authors:  Taylor M Coe; Zhi Ven Fong; Samuel E Wilson; Mark A Talamini; Keith D Lillemoe; David C Chang
Journal:  J Gastrointest Surg       Date:  2015-10-05       Impact factor: 3.452

Review 2.  Publication bias in Kienböck's disease: systematic review.

Authors:  Lee Squitieri; Elizabeth Petruska; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2010-03       Impact factor: 2.230

3.  Barriers to shared decisions in the most serious of cancers: a qualitative study of patients with pancreatic cancer treated in the UK.

Authors:  Sue Ziebland; Alison Chapple; Julie Evans
Journal:  Health Expect       Date:  2014-12-11       Impact factor: 3.377

4.  A comparison of open and minimally invasive surgery for hepatic and pancreatic resections using the Nationwide Inpatient Sample.

Authors:  Aslam Ejaz; Teviah Sachs; Jin He; Gaya Spolverato; Kenzo Hirose; Nita Ahuja; Christopher L Wolfgang; Martin A Makary; Matthew Weiss; Timothy M Pawlik
Journal:  Surgery       Date:  2014-07-10       Impact factor: 3.982

5.  Report of 2,087,915 surgical admissions in U.S. children: inpatient mortality rates by procedure and specialty.

Authors:  Fizan Abdullah; Alodia Gabre-Kidan; Yiyi Zhang; Leilani Sharpe; David C Chang
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

6.  The impact of provider surgical volumes on survival in children with primary tumors of the central nervous system--a population-based study.

Authors:  Ole Solheim; Øyvind Salvesen; Johan Cappelen; Tom Børge Johannesen
Journal:  Acta Neurochir (Wien)       Date:  2011-03-10       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.